Heilongjiang, China

Xin Jin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Harbin Pharmaceutical Group Co., Ltd. General Pharmaceutical Factory. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Jin. Retrieved from https://idiyas.com/inventor/xin-jin-t41683u4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Xin Jin: A Pioneer in Diaza-Benzofluoranthrene Compounds

Introduction: Xin Jin is an accomplished inventor based in Heilongjiang, China, known for his significant contributions to the field of pharmaceuticals. With a focus on innovative compounds, Jin's work has paved the way for advancements in medical treatment, particularly in addressing critical health conditions.

Latest Patents: Xin Jin holds a patent for "Salts and crystal forms of diaza-benzofluoranthrene compounds." This groundbreaking invention discloses various salts, including hydrochloride, citrate, phosphate, and sulfate salts of compound 1. Alongside these crystal forms, the patent details a preparation method and underscores their potential use in formulating medications for the treatment of cerebral apoplexy and epilepsy.

Career Highlights: Xin Jin's professional journey is marked by his position at Harbin Pharmaceutical Group Co., Ltd., specifically within the General Pharmaceutical Factory. This esteemed company provides an excellent platform for fostering innovation in pharmaceuticals, which has enabled Jin to develop his innovative patent.

Collaborations: Collaboration is central to Xin Jin's work, with notable coworkers such as Qingqing Lu and Shenyi Shi contributing to his projects. Working alongside such talented individuals enhances the creative and technical aspects of his inventions, furthering the potential impact of their work in the medical field.

Conclusion: Xin Jin exemplifies the spirit of innovation in the pharmaceutical industry. His patent on diaza-benzofluoranthrene compounds not only showcases his inventive prowess but also highlights the importance of collaborative efforts in advancing medical science. As he continues to work with esteemed colleagues at Harbin Pharmaceutical Group Co., Ltd., Xin Jin is undoubtedly paving the way for future breakthroughs in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…